Global Regulatory Working Group
Elaine Katrivanos
Vice President, Regulatory Affairs
Tempus AI
Co-Chairs
Jennifer Dickey, PhD
Head of Regulatory and Quality
PGDx
Current Projects
Exploring the possibility of hosting an in-person meeting in Brussels to engage with several European organizations and formalize a project.
The Global Regulatory WG is collaborating with the Data Science working group in writing a manuscript to showcase how BLOODPAC’s standardization efforts in the US could also make an impact in the EU.
Qualitative analysis through survey with US and EU BLOODPAC members on MTDE and AV protocol usage.
Participating Organizations
AstraZeneca, Bristol Myers Squibb (BMS), Cancer Patients Europe, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), European Liquid Biopsy Society (ELBS), European Organisation for Research and Treatment of Cancer (EORTC), Exact Sciences, Friends of Cancer Research (FOCR), GlaxoSmithKline (GSK), International Quality Network for Pathology (IQN Path), International Society of Liquid Biopsy (ISLB), Johnson & Johnson, Labcorp, MDx CRO, Merck, Natera, Personalis, Tecan, Tempus AI, Thermo Fisher Scientific
Meetings
This working group meets on zoom every other Tuesday from 11:00 - 12:00 PM EST.
Special workshops and sessions:
Not applicable at this time.